Showing results (111-120 of 439) with videos related to
Sort By:
Pageof 44
European Journal of Haematology|September 7, 2004
Paroxysmal cold haemoglobinuria as a tardive complication of idiopathic myelofibrosisMassimo Breccia, Gianna Maria D'Elia, Gabriella Girelli, et al.Leukemia Research|December 9, 2008
Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual diseaseMassimo Breccia, Laura Cannella, Caterina Stefanizzi, et al.Leukemia Research|August 22, 2015
Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome - Emphasis on optimized dosing schedules and new formulationsFlorian Nolte, Emanuele Angelucci, Massimo Breccia, et al.Expert Opinion on Pharmacotherapy|March 15, 2024
Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitorsAlessandro Costa, Emilia Scalzulli, Ida Carmosino, et al.Leukemia & Lymphoma|November 25, 2024
Clinical and biological advances of critical complications in acute myeloid leukemiaAlessandro Costa, Emilia Scalzulli, Ida Carmosino, et al.Expert Review of Hematology|November 18, 2020
Tyrosine kinase inhibitor discontinuation in the management of chronic myeloid leukemia: a critical review of the current practiceMassimo Breccia, Fabio Efficace, Gioia Colafigli, et al.European Journal of Haematology|November 1, 2016
TPO-RAs in pITP: description of a case series and analysis of predictive factors for responseMaria Gabriella Mazzucconi, Cristina Santoro, Erminia Baldacci, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 25, 2016
Psychological well-being and social support in chronic myeloid leukemia patients receiving lifelong targeted therapiesFabio Efficace, Massimo Breccia, Francesco Cottone, et al.Cancer Letters|January 8, 2013
Delayed cytogenetic and major molecular responses associated to increased BMI at baseline in chronic myeloid leukemia patients treated with imatinibMassimo Breccia, Giuseppina Loglisci, Adriano Salaroli, et al.Leukemia Research|August 3, 2013
Profiling chronic myeloid leukemia patients reporting intentional and unintentional non-adherence to lifelong therapy with tyrosine kinase inhibitorsFabio Efficace, Gianantonio Rosti, Francesco Cottone, et al.Pageof 44